More than a fifth of stable diabetes patients examined showed slight elevations in cardiac troponin I levels and had a 50% increased risk of major adverse cardiac events over three years, researchers found. The results, published in Diabetes Care, "imply that any detectable cTnI level should warrant consideration for more globally aggressive risk-reduction efforts, including closer evaluation and long-term monitoring, and such intervention efforts may focus beyond glycemic-control measures," said researcher Dr. W.H. Wilson Tang.
Higher heart risk seen with increased troponin rates in diabetes
SmartBrief Job Listings for Health Care
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan